NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Did they have an international patent that should apply in Columbia?

Have no clue (nor do I care) what the patent status is in Columbia. But here in US, Gleevec is already going generic.

I find it difficult to believe that Hatch's puppy dog can rationally argue that Columbia is acting as a global IP infringer there, when the US is allowing the exact same generic.

Disagree with the article on the NIH development issue though. It takes a hell of a lot of effort and cash to get a drug through the process. This was virtually all provided by the company after the initial work. The US has some rights due to such, but should not be involved here (either way).

BTW, the US law that facilitated the generic being on the market this soon in the US? Hatch-Waxman Act.